CPT 80061: Complete Guide to Lipid Panel Billing, Coding, Documentation & Reimbursement in 2026
Quick Answer: What Is CPT 80061?
The short version CPT 80061 is the lipid panel code: total cholesterol, direct HDL cholesterol, and triglycerides performed together. When a laboratory performs all three as an ordered panel, the panel code is reported instead of the three component codes. Coverage and payment depend on medical necessity, the payer, and the fee schedule or contract behind it. |
CPT 80061 at a Glance
Item | Practical Explanation |
CPT code | 80061 |
Service | Lipid panel |
Major components | Total cholesterol, HDL cholesterol, triglycerides |
Setting | Clinical laboratory testing |
Key coding issue | Panel vs individual component reporting |
Reimbursement | Payer, coverage, medical necessity, CLFS or contract rules |
What Does CPT 80061 Include?
The panel has a fixed recipe: total cholesterol (82465), HDL cholesterol by direct measurement (83718), and triglycerides (84478). Each test has its own code, but when the full set is performed as a panel, 80061 replaces them. A calculated LDL value doesn’t earn its own line. Direct LDL (83721) is a separate test that applies only when the lab actually measures it.
Component | Code | What it represents | Billing consideration |
Total cholesterol | 82465 | Overall cholesterol level | Part of the defined panel |
HDL cholesterol | 83718 | High-density lipoprotein cholesterol | Part of the defined panel |
Triglycerides | 84478 | Blood triglyceride level | Part of the defined panel |
Figure 1. How the lipid panel is built
CPT 80061 vs Individual Component Testing
This is where lipid claims most often go wrong. NCCI’s 2026 Medicare manual says that when every test in a CPT-defined panel is performed, the panel code is billed, and panel codes apply when tests are ordered as that panel. Its own example: cholesterol, triglycerides, and HDL ordered individually should be reported as 80061. NCCI pairs 80061 with each component, so billing all four triggers an edit.
Component codes belong on the claim only when the panel wasn’t complete, or a component was legitimately repeated and the record supports it.
FULL PANEL All three tests performed as ordered. One line, 80061. Confirm the order and results match. | INDIVIDUAL COMPONENTS Fewer than three performed. Report what was actually done, and confirm the panel isn’t complete. |
Situation | What the billing team should review |
Full lipid panel performed | Panel coding, on a single line |
Individual tests performed | Whether all three panel tests were done and ordered together |
Component test repeated | Current NCCI and modifier guidance, plus medical necessity |
Additional testing ordered | Whether it belongs to the panel or is a separate test |
Follow-up or expanded testing | Separate code, NCCI pairing, and payer review |
When Is CPT 80061 Reported?
Typical situations: preventive testing where the plan covers it, monitoring lipid-lowering therapy, cardiovascular risk evaluation, follow-up after an abnormal result, and other clinically appropriate testing. None guarantees coverage. Medical necessity, diagnosis coding, frequency limits, payer policy, and the patient’s benefits all sit between the order and the payment.
Medical Necessity, Diagnosis Coding, and Screening vs Diagnostic Testing
A lipid panel can be coded perfectly and still deny because the diagnosis doesn’t fit the reason for testing. Payers read the test, the reported diagnosis, and the coverage policy together. The diagnosis must come from the patient’s record, not from a list of codes known to pass.
Screening means testing without signs, symptoms, or a known condition. Diagnostic or monitoring testing follows symptoms, a diagnosis, or treatment. Under Medicare’s lipid NCD, testing an asymptomatic patient is screening even with risk factors such as family history or tobacco use. Commercial plans and Medicaid write their own rules.
| Screening (Medicare example) | Diagnostic or monitoring (Medicare example) |
Reason | No signs, symptoms, or known condition | Symptoms, a diagnosis, or therapy follow-up |
Basis | Cardiovascular screening benefit | NCD 190.23 and MAC policy |
Diagnosis | Z13.6, encounter for cardiovascular screening | A specific diagnosis on the covered list; vague ones may not support necessity |
Frequency | Once every five years | Varies by scenario, such as annual panels when monitoring therapy |
Figure 2. Screening vs diagnostic lipid testing
COVERAGE Does the payer cover this service for this patient, under its benefit, diagnosis, and frequency rules? | PAYMENT How does the fee schedule, contract, or payer policy set the amount? Different question, different answer. |
CPT 80061 Medicare Billing
Medicare coverage isn’t determined by the CPT code alone. Teams commonly review:
• Diagnosis: screening claims use the screening diagnosis. Diagnostic claims need a diagnosis on the NCD’s current covered-code list. MAC articles may add detail.
• Frequency: the screening benefit and the NCD both carry frequency expectations. Claims beyond them can deny unless documentation supports more.
• Order and CLIA: the NCD expects an order from the treating physician or qualified practitioner, and the right CLIA certificate at the lab.
• Edits: NCCI panel edits apply, covered next.
CPT 80061 and the Clinical Laboratory Fee Schedule
Medicare generally pays for clinical diagnostic laboratory tests like this one under the Clinical Laboratory Fee Schedule (CLFS), not the physician fee schedule. CMS builds it from the weighted median of private payor rates labs report under PAMA.
For 2026: the Consolidated Appropriations Act, 2026 (signed February 3) set data reporting for May 1 through July 31, and CMS applies no CLFS reduction in 2026. From 2027 through 2029, reductions of up to 15% a year can apply. CMS also issues quarterly updates, so pull the current CLFS file instead of quoting an older table.
Figure 3. 2026 dates that touch lipid panel claims
NCCI and CPT 80061
Billing rule to remember If all three panel tests were performed, report 80061, not 80061 plus 82465, 83718, and 84478. The NCCI pairing exists to stop unbundling. |
The edits allow a modifier in one narrow case: a component test repeated on the same date when the repeat is medically reasonable and necessary. NCCI names modifiers 59 or 91 for that. Repeating a test to confirm an initial result, to work around specimen or equipment trouble, or when one normal reportable result would do doesn’t qualify.
The question isn’t “which modifier clears the edit?” It’s “was a second, necessary test performed, and does the record show why?” A modifier documents a real circumstance. It can’t create one or guarantee payment.
Related lipid edits: direct LDL (83721) isn’t reported for a calculated LDL, and NMR lipoprotein quantitation (83704) generally isn’t reported the same day as 80061. NCCI also warns against shifting services to another date to avoid an edit. These are Medicare rules; Medicaid publishes its own 2026 manual, and commercial plans set their own edits. Q4 2026 PTP and MUE files take effect October 1.
Documentation Requirements for CPT 80061
Requirements vary by payer, setting, and circumstance. Treat this as a baseline.
☐ Ordering provider, with a signed order where the payer requires one
☐ Test ordered, and whether it was ordered as a panel
☐ Clinical reason or test indication
☐ Diagnosis linked to the reason for testing
☐ Patient identifiers and date of service
☐ Specimen information, where applicable
☐ Results or report for each test performed
☐ Support for frequency and any repeat testing
☐ Payer-specific items
Medicare’s lipid NCD warns that missing necessity documentation, or missing proof of the treating provider’s order, can lead to denial.
Common CPT 80061 Billing Mistakes
Billing check Don’t review a lipid claim by asking only, “Was the test performed?” Confirm the code matches the tests actually performed and the payer’s rules. |
Billing check A rate pulled from last year’s fee schedule isn’t a 2026 answer. |
CPT 80061 Reimbursement: What Determines Payment?
Correct coding doesn’t guarantee reimbursement, and this guide doesn’t quote a rate. Payment can shift with:
Payer and plan type Medicare, Medicaid, commercial | Fee schedule or contract CLFS or a negotiated rate | Coverage and necessity Diagnosis, frequency, payer policy |
Claim edits NCCI, MUE, payer-specific edits | Documentation Orders, results, indication | Billing status Lab type, place of service, who bills |
Two organizations can submit the same code and see different outcomes because their contracts, benefits, edit sets, and chart support differ. Coding errors also cost more than one claim: rework, delayed payment, A/R growth, compliance exposure, and admin workload. For a wider view of denials and clean-claim performance, see our revenue cycle management services.
Realistic Claim Review Scenario
Hypothetical example, not a client case or payer policy: a lab receives a lipid panel order for a patient taking cholesterol-lowering medication.
1. Order Lipid panel ordered for a patient on lipid-lowering therapy. | 2. Reason The record shows monitoring, not screening. | 3. Code All three tests ran as a panel, so 80061 is evaluated. |
4. Components Results exist for all three. No repeat, no direct LDL. | 5. Diagnosis The charted diagnosis fits the monitoring reason and the payer’s list. | 6. Payer and submit Frequency and NCCI edits checked. Lines match: submit. Unclear: hold. |
Before You Submit CPT 80061
Before you submit CPT 80061 |
☐ Correct lipid panel code reviewed ☐ Component tests confirmed ☐ Panel vs individual testing evaluated ☐ Diagnosis supports the reason for testing ☐ Screening vs diagnostic context reviewed ☐ Medicare or payer coverage checked ☐ Frequency requirements reviewed ☐ NCCI edits reviewed when applicable ☐ Current CLFS or payment guidance checked ☐ Documentation supports the service ☐ Payer-specific policy reviewed |
Should I stop and review this claim? |
☐ Component codes appear alongside 80061 ☐ Diagnosis doesn’t match the reason for testing ☐ Screening and diagnostic context are mixed ☐ Unexpected denial ☐ Payer-specific edit ☐ Fee-schedule information may be outdated |
A flag is a prompt to look, not proof of an error.
CPT 80061 Quick Check
Tick an answer, then compare with the key.
1. What does CPT 80061 represent?
☐ A single cholesterol test
☐ The defined lipid panel
☐ Any test that includes LDL
2. Should component tests automatically be billed with the panel?
☐ No, only for a supported repeat or separate need
☐ Yes, always
☐ Yes, if the payer is Medicare
3. What should be reviewed before assuming Medicare payment?
☐ Only the CPT code
☐ The lab’s test volume
☐ Coverage, diagnosis, frequency, and CLFS guidance
4. What role does medical necessity play?
☐ It is optional when the code is correct
☐ It links the test, diagnosis, and policy
☐ It applies only to screening
Key: 1 b (one code for three tests). 2 a (NCCI pairs panel and components). 3 c (coverage and payment differ). 4 b (a correct code alone doesn’t guarantee payment).
CPT 80061 FAQs
What is CPT 80061 used for?
It reports a lipid panel: total cholesterol, direct HDL cholesterol, and triglycerides performed together.
What tests are included in CPT 80061?
Total cholesterol (82465), HDL cholesterol (83718), and triglycerides (84478). A calculated LDL isn’t billed separately; direct LDL (83721) is its own test.
Can CPT 80061 be billed with 82465, 83718, or 84478?
Generally not when all three were performed as the panel. Only a legitimately repeated, necessary component may qualify for an NCCI modifier.
Does Medicare cover CPT 80061?
It depends. Medicare has a screening benefit for people without signs or symptoms and a national policy for diagnostic testing, each with diagnosis and frequency rules. The code alone doesn’t decide coverage.
What diagnosis supports CPT 80061?
The one the patient’s record supports. Medicare screening uses Z13.6. Diagnostic testing needs a diagnosis on the current covered-code list or your MAC’s policy. Other payers use their own lists.
How is CPT 80061 reimbursed, and is it paid under the CLFS?
Medicare generally pays it under the CLFS. Commercial payers and Medicaid may use contracts or their own fee schedules, and a listed code isn’t covered for every patient. Check the current CMS CLFS file and your contracts.
What should I do if CPT 80061 is denied?
Read the denial reason, then check components, diagnosis, frequency, and payer policy before resubmitting. Appeal with documentation when the record supports the service.
Disclaimer: This article is general education, not legal, coding, billing, compliance, or clinical advice, and creates no client relationship. CPT coding changes, payer policies differ, and Medicare requirements may differ from commercial insurance. Coverage and reimbursement depend on circumstances. Verify current official guidance and consult your compliance officer before submitting claims. Sources reviewed as of September 21, 2026. Nothing here guarantees payment or results. CPT® is a registered trademark of the AMA; descriptions are paraphrased.
